Neuronetics Inc. (STIM): Market Cap to Revenue

Symbol and logo of brand Neuronetics Inc. (STIM)

Low geopolitical risks ensure stable sales across developed countries. Consistent demand for services and consumables for installed systems creates predictable revenue. The capitalization-to-sales ratio reflects the market's reaction to news, with the value holding at 0.70. Neuronetics, Inc. (STIM) leads the TMS segment, offering psychiatrists the NeuroStar system for drug-free depression treatment.

STIM Neuronetics Inc. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for NeuroStar (STIM)

- share price and consensus valuation forecast:
Price Performance Chart neurostar.com|STIM - Price Target Chart
- stock exchange capitalization data:
Market Valuation NeuroStar|STIM - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Neuronetics|STIM - Book Capitalization|Capitalization to Book Value Ratio neurostar.com|STIM - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Neuronetics, Inc.|STIM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Neuronetics, Inc|STIM - Company Aggregate Debts|Debts to Book Capitalization NeuroStar|STIM - Company Long-Term Debt|Company Short-Term Debt Neuronetics|Intermediate Coverage Ratio neurostar.com
- earnings and multiples data:
STIM - Net Profit|Expected Net Profit Neuronetics, Inc.|STIM - Price to Earnings Ratio|Forward Price to Earnings Multiple Neuronetics Inc.|STIM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple NeuroStar|STIM - Operating profit EBITDA|Net earnings per share for the last four quarters Neuronetics|STIM - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months neurostar.com|STIM - Earnings per share growth in current year|Expected earnings per share growth for next year Neuronetics, Inc.
- issuer revenue and sales details:
STIM - Revenue and Sales Volume|Company Expected Sales Volume neurostar.com|STIM - Price-to-Revenue Ratio|Market Cap to Projected Revenue NeuroStar
General company analysis:STIM neurostar.com
Core merchandise of Neuronetics, Inc.

To qualitatively assess an asset, an investor analyzes the company's price-to-sales ratio, which determines the market price of each unit of sales and signals whether the business is overbought or undervalued. This chart reflects market expectations regarding the expansion of Neuronetics, Inc. (STIM), where a rising multiple confirms capital's confidence in the success of the new strategy to expand insurance coverage for brain stimulation systems.

Competitors of Neuronetics, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|xtantmedical.com (XTNT) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio NMTC|MODD (Modular Medical Inc) - P/S Multiple|Price to Sales Myomo Inc. MYO|Market Cap to Revenue COCH (Envoy Medical, Inc)|P/S Multiple Vivos Therapeutics Inc (VVOS)|Price-to-Revenue Ratio enVVeno Medical NVNO|Market Capitalization-to-Revenue Ratio SINT|TNON - Price-to-Revenue Ratio|Price to Sales ReWalk Robotics|autonomix.com (AMIX) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio IVF|BBLG (Bone Biologics) - P/S Multiple|Price to Sales axonics.com AXNX|Market Cap to Revenue BIOL (BIOLASE)|Market Cap to Sales Volume DYNT|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)